Why scientists' failure to understand GM opposition is stifling debate and halting progress
By Sarah Hartley,
The Conversation
| 07. 07. 2016
Genetically modified crops are safe for human consumption and have the potential to feed the world and improve human health, scientists have been telling us for years. On June 30, 110 Nobel laureates from around the world signed a letter demanding that the environmental pressure group Greenpeace stop its campaign against GM crops. How many people must die before we consider this a “crime against humanity”? the letter asks.
The scientists are accusing Greenpeace of ignoring facts, misrepresenting risks and benefits, failing to recognise the authority of science and relying on emotion and dogma. They are particularly concerned about Greenpeace’s opposition to Golden Rice, which has an added gene that boosts vitamin A levels – something scientists claim is much needed in many poor populations.
But Greenpeace argues that there are cheaper and more effective alternatives to Golden Rice and that GM rice developers are out of touch with the needs of local populations. It also claims developers are downplaying the risk that GM rice will contaminate traditional and organic rice crops.
The eminent scientists appear to have learned...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
